Simon Business School
article

Faculty Profile

Ronald W Hansen
Clinical Professor Emeritus
Phone: 585.275.2668
Office: 2-341 Carol Simon Hall

Bio

As Senior Associate Dean for Program Development, Ronald Hansen was responsible for Simon’s international program development, undergraduate program and involved in the Technical Entrepreneurship And Management (TEAM) MS and the Technical Entrepreneurship and Management in Biomanufacturing and Therapeutic Development (TEAM-BMTD) programs. He served as area coordinator for the concentrations of Business Environment and Public Policy, Health Sciences Management and International Management. Prior to this position, Ron served as Senior Associate Dean for Faculty and Research for 21 years. He came to the School in 1971 as an assistant professor and became director of the Systems Analysis Program in 1972. From 1977 to 1986, he was the associate director of the Center for Research in Government Policy and Business, now the Bradley Policy Research Center. He briefly left the Simon School to become the first recipient of the Merrell Dow Professorship of Pharmaceutical Administration in the College of Pharmacy at The Ohio State University (1986–88). Hansen is widely recognized for his scholarly research in drug-development policy and in the regulation of the pharmaceutical industry. He helped to establish and collaborates on research with the Tufts Center for the Study of Drug Development. Hansen was on the editorial board of the Journal of Research in Pharmaceutical Economics. He was a member of the National Advisory Council on Health Care Technology Assessment (1985–88) and the Committee on the Children’s Vaccine Initiative, Institute of Medicine, National Academy of Sciences (1992–93). Hansen earned a B.A. degree in mathematics from Northwestern University, and an M.A. degree in economics and a Ph.D. in economics from the University of Chicago.

Teaching Interests

Evolving Medical Markets, Medical Device Development & Marketing, Pharmaceutical Economics, Medical Entrepreneurship, Healthcare Business Models, International Management

Research Interests

Hansen is widely recognized for his scholarly research in drug-development policy and in the regulation of the pharmaceutical industry. He helped to establish and collaborates on research with the Tufts Center for the Study of Drug Development. Hansen was on the editorial board of the Journal of Research in Pharmaceutical Economics. He was a member of the National Advisory Council on Health Care Technology Assessment (1985–88) and the Committee on the Children’s Vaccine Initiative, Institute of Medicine, National Academy of Sciences (1992–93).

Professional History

Clinical Professor Emeritus
University of Rochester Simon Business School
2016 -
William H. Meckling Professor of Business Administration; Sr. Associate Dean for Program Development
University of Rochester Simon Business School, Rochester NY
July 2009 - 2016
Senior Associate Dean for Faculty and Research
University of Rochester Simon School of Business, Rochester NY
July 1999 - June 2009
Associate Dean for Academic Affairs
University of Rochester Simon School of Business, Rochester NY
July 1988 - June 1999
Assocate Professor, Merrel Dow Professorship
Ohio State University College of Pharmacy, Division of Pharmaceutical Administration, Columbus OH
July 1986 - August 1988
Associate Director
Graduate School of Management (renamed William E. Simon Graduate School of Business Administration November 1986), Center for Research in Government Policy and Business (renamed Bradley Policy Research Center November 1987), Rochester NY
June 1977 - July 1986
Visiting Professor of Economics
Colgate-Rochester Divinity, Rochester NY
1980 - 1984
Assisant Professor
University of Rochester Graduate School of Management, Rochester NY
September 1971 - June 1977
University of Western Ontario, London Ontario, Canada
June 1970 - August 1970

Education

University of Chicago - 1982
Ph D
Economics
University of Chicago - 1970
MA
Economics
Northwestern University - 1966
BA
Mathematics

Publications

2016
Innovation in the Pharmaceutical Industry: New Estimates of R&D costs
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Economics
Volume: 47
2015
The Cost of Drug Development (Letterto the Editor)
Contribution Type: Journal Article, Professional Journal
Journal/Publisher/Proceedings Publisher: New England Journal of Medicine
Volume: 372
Issue: 20
2008
Misleading Congress about Drug Development: Reply
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Politics, Policy and Law/Duke University Press
Volume: 33
2005
Reply – Extraordinary Claims Require Extraordinary Evidence
Contribution Type: Journal Article, Professional Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier
Volume: 24
Issue: 2005
2005
Reply - Setting the Record Straight on Setting the Record Straight: Response to the Light and Warburton Rejoinder
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier
Volume: 24
2004
Assessing claims about the cost of new drug development: a critique of the Public Citizen and TB Alliance reports
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Tufts Center for the Study of Drug Development, Tufts University
2003
The Price of Innovation: New Estimates of Drug Development Costs
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier
Volume: 22
2000
Regulation of the Pharmaceutical Industry (Book Chapter)
Contribution Type: Book, Chapter in Scholarly Book-New
Journal/Publisher/Proceedings Publisher: American Health Care: Government, Market Processes, and the Public Interest
1996
Costs and Benefits of Cost-Benefit Analysis in Pharmaceutical Promotion and Utilization Decisions,” Chapter 14 in Competitive Strategies in the Pharmaceutical Industry
Contribution Type: Book, Chapter in Non-Scholarly Book-New
Journal/Publisher/Proceedings Publisher: AEI Press
1996
Science and innovation: The US pharmaceutical industry during the 1980s
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Economic Literature
Volume: 34
Issue: 2
1995
FDA regulation of the pharmaceutical industry
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Hazardous to Our Health? FDA Regulation of Health Care Products
1995
Research And Development Costs For New Drugs By Therapeutic Category: A Study of the US Pharmaceutical Industry
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: PharmcoEconomics / Adis International Ltd
Volume: 7
Issue: 2
1991
Cost of Innovation in the Pharmaceutical Industry
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier
Volume: 10
1991
Modeling of Cost Analysis
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Pharmaceutical Economics
Volume: 1
Issue: 2
1989
Compensation Alternatives for Occupational Disease and Disability
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: The Journal of Risk and Insurance / Wiley
Volume: 56
Issue: 2
1987
Effects of Cost Containment on Pharmaceutical Innovation
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Clinical Research Practices and Drug Regulatory Affairs
Volume: 5
Issue: 5-6
1987
Pharmaceutical Regulation: The Past and Future Twenty-five Years
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Health Economics: Prospects for the Future, Croom Helm, London, England
1984
Success Rate in the United States Drug Development System
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Clinical Pharmacology and Therapeutics
Volume: 36
Issue: 5
1983
International Issues of Drug Regulation
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: Journal of Institutional and Theoretical Economics
Volume: 139
Issue: 3
1982
Costs and benefits of innovation and regulation in the pharmaceutical industry
Contribution Type: Book, Scholarly-New
Journal/Publisher/Proceedings Publisher: University of Chicago
1979
The pharmaceutical development process: estimates of development costs and times and the effects of proposed regulatory changes
Contribution Type: Book, Scholarly-New
Journal/Publisher/Proceedings Publisher: Center for the Study of Drug Development, Department of Pharmacology and Toxicology, University of Rochester Medical Center
1978
Technological Innovation and Government Regulation of Pharmaceuticals in the United States and Great Britain: Executive Summary
Contribution Type: Book, Scholarly-New
Journal/Publisher/Proceedings Publisher: School of Medicine and Dentistry, Graduate School of Management, University of Rochester
1977
Comments on the proposed change in FDA’s trade secrets policy.
Contribution Type: Journal Article, Academic Journal
Journal/Publisher/Proceedings Publisher: American journal of pharmacy and the sciences supporting public health
Volume: 149
Issue: 5

Current Research Programs

Innovation In The Pharmaceutical Industry: New Estimates of R&D Costs
Resubmitted to JHE in June 2015; Accepted for publication for May 2016.
Go to the top of the page
Get more information about Simon
Apply to Simon